National Trends in Drug Payments for HIV Preexposure Prophylaxis in the United States, 2014 to 2018 : A Retrospective Cohort Study.

CONCLUSION: Third-party and OOP payments per 30 TDF-FTC tablets increased annually. The $2.08 billion in PrEP medication payments in 2018 is an underestimation of national costs. High costs to the health care system may hinder PrEP expansion.
PRIMARY FUNDING SOURCE: Centers for Disease Control and Prevention.
PMID: 32894696 [PubMed - as supplied by publisher]

Source: Annals of Internal Medicine - September 7, 2020 Category: Internal Medicine Authors: Furukawa NW, Zhu W, Huang YA, Shrestha RK, Hoover KW Tags: Ann Intern Med Source Type: research